Medical/Pharmaceuticals

Medicom Announces New Mask Production Facility in Singapore

MONTREAL, June 4, 2020 /PRNewswire/ -- The Medicom Group, ("Medicom"), one of the world's leading manufacturers of surgical and respiratory masks, has announced the further expansion of its global footprint with the opening of a mask manufacturing facility inSingapore. Established as the KHM Engi...

2020-06-04 03:41 484

Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine

AGC Biologics partners with Novavax to produce NVX-CoV2373 component SEATTLE, June 3, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced that it will partner withNovavax, Inc. (NASDAQ: NVAX), a late-stage biot...

2020-06-03 19:00 632

Toni Nesci Named Head of Mayne Contract Services and New Website Launched

ADELAIDE, Australia, June 3, 2020 /PRNewswire/ -- Toni Nesci has been appointed Head of Mayne Contract Services, a division of the Mayne Pharma family. Mayne Contract Services, based in Salisbury,South Australia is the full-service pharmaceutical development and manufacturing business unit create...

2020-06-03 10:39 684

Eleva's Drug Candidate to Be Examined for Use in COVID-19 Treatment

FREIBURG, Germany, June 3, 2020 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the co...

2020-06-03 10:00 676

Innovent Announces the Preliminary Results of the Anti-CTLA-4 Monoclonal Antibody IBI310 in a Phase 1 Clinical Study

SUZHOU, China, June 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announces...

2020-06-03 07:30 1552

Hydrocyn® aqua Inactivates the Coronavirus Causing COVID-19

STOCKHOLM, June 3, 2020 /PRNewswire/ -- The effect of Hydrocyn® aqua (Hydrocyn) on the new coronavirus (SARS-CoV-2) causing COVID-19 has been confirmed. Tests performed by the Swedish National Veterinary Institute show that 99.9% of the virus particles were killed after exposure to Hydrocyn. Bact...

2020-06-03 00:54 864

Tigermed Lauded by Frost & Sullivan for Its Rapid, Large-Scale Clinical Developmental Services

Tigermed's comprehensive service portfolio and robust infrastructure cement its status as a strategic partner for the pharmaceuticals industry LONDON, June 2, 2020 /PRNewswire/ -- Based on its recent analysis of the Chinese contract research organizations (CROs) market, Frost & Sullivan recogniz...

2020-06-02 22:00 2060

DERMALOG Fever Check at Clever Fit Gym

KALTENKIRCHEN and HAMBURG, Germany, June 2, 2020 /PRNewswire/ -- After a mandatory corona break of several weeks, sports facilities and fitness studios inGermany are reopening. Operators have to comply with numerous hygiene regulations to minimize infection risks for customers and employees. This...

2020-06-02 21:46 889

Ajinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem Joint Venture in India

WETTEREN, Belgium, June 2, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that it has completed the acquisition of Granules OmniChem Private Limited, purchasing ...

2020-06-02 20:04 878

Technopath Clinical Diagnostics Launches the First Not-For-Profit COVID-19 Antibody Testing Initiative to Support Companies in Ireland

BALLINA (County Tipperary), Ireland, June 2, 2020 /PRNewswire/ -- Technopath Clinical Diagnostics today announced that it is rolling out COVID-19 antibody testing inIreland to help businesses navigate a safer workplace re-entry. This initiative will provide key services to all industries and will...

2020-06-02 19:00 772

QPS Awarded Two 2020 CRO Leadership Awards

NEWARK, Delaware, June 2, 2020 /PRNewswire/ -- QPS is a GLP/GCP-compliant and CLIA-certified contract research organization (CRO) delivering discovery, preclinical, and clinical drug development services since 1995.  An award-winning leader focused on bioanalytics and clinical trials, QPS, has be...

2020-06-02 18:55 684

PepsiCo Thailand Commits 18,000,000 Baht to Supporting COVID-19 Relief Efforts in Thailand

Ms. Wei Wei Yao, SVP & GM, Asia BU and China Beverages BU of Pepsi Cola (Thai) Trading Co., Ltd.BANGKOK, June 2, 2020 /PRNewswire/ -- PepsiCo Thailand, Suntory PepsiCo Beverages Thailand, and The PepsiCo Foundation have partnered with Raks Thai Foundation to reach the most vulnerable communities...

2020-06-02 18:09 879

Cellenkos(R) Inc. Announces FDA Clearance to Initiate Phase 1 Double- Blinded, Randomized, Placebo-Controlled Trial of Cryopreserved Cord Blood-Derived T-Regulatory Cells (CK0802) for Treatment of COVID-19 Associated Acute Respiratory Distress Syndrome

HOUSTON, June 2, 2020 /PRNewswire/ -- Cellenkos Inc., a privately held, clinical stage biotech company announced today that the US Food & Drug Administration (FDA) has cleared the way to initiate a Phase 1 clinical trial of CK0802 (Cryopreserved Cord Blood Derived T-Regulatory Cells) for treatmen...

2020-06-02 18:00 870

Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified

SEOUL, South Korea, June 2, 2020 /PRNewswire/ -- Lunit today announced that its AI solution for breast cancer, Lunit INSIGHT MMG, has been CE certified. The medical software was certified onMay 26th, making it now commercially available across the European Economic Area. The certified software, ...

2020-06-02 16:00 424

Modular Bioscience Acquires Exclusive License to University of Illinois Urbana Champaign Artificial Restriction Enzyme Technology

SILICON VALLEY, Calif., June 2, 2020 /PRNewswire/ -- Modular Bioscience, an early stage biotechnology company based in Silicon Valley, today announced that it has executed a definitive agreement with theUniversity of Illinois at Urbana-Champaign for an exclusive global patent license to a novel a...

2020-06-02 13:28 464

Adagio Medical Receives CE Mark Approval for its iCLAS(TM) Cryoablation System and Prepares for European Commercial Launch

LAGUNA HILLS, Calif., June 2, 2020 /PRNewswire/ -- Adagio Medical, Inc., announces that it has received CE Mark approval for its ultra-low temperaturei ntelligentContinuous Lesion Ablation System (iCLAS) for the endocardial treatment of paroxysmal (PAF) and persistent (PsAF) atrial fibrillation an...

2020-06-02 11:25 866

Innovent Announced the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study

SUZHOU, China, June 2, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic,  autoimmune and other major diseases, announced the ...

2020-06-02 07:30 2386

AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings

AGC Biologics acquires Boulder, Colorado U.S.A. facility to increase global capacity and extend manufacturing scale SEATTLE, June 2, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the purchase of a state-of-the...

2020-06-02 06:00 1065

Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR®

SHANGHAI, June 1, 2020 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today held a special signing ceremony as part of the "We Care About Mental Health" initiative, marking the start of three new strategic partnerships across the region. As part of the initiative, Luye Pharma granted Alvogen Kor...

2020-06-01 15:22 1123

Henlius and Accord Receive Positive CHMP Opinion for Oncology Biosimilar, HLX02 (Trastuzumab)

SHANGHAI, June 1, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord) jointly announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing aut...

2020-06-01 13:48 1174
12345 ... 169